These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29663050)

  • 1. Biosynthesis and production of quercitols and their application in the production of pharmaceuticals: current status and prospects.
    Itoh N
    Appl Microbiol Biotechnol; 2018 Jun; 102(11):4641-4651. PubMed ID: 29663050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel (-)-vibo-quercitol 1-dehydrogenase from Burkholderia terrae suitable for production of (-)-vibo-quercitol from 2-deoxy-scyllo-inosose.
    Itoh N; Kurokawa J; Toda H; Konishi K
    Appl Microbiol Biotechnol; 2017 Oct; 101(20):7545-7555. PubMed ID: 28905086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of 2-deoxy-scyllo-inosose (DOI)-assimilating yeasts and cloning and characterization of the DOI reductase gene of Cryptococcus podzolicus ND1.
    Ara S; Yamazaki H; Takaku H
    J Biosci Bioeng; 2018 Apr; 125(4):397-406. PubMed ID: 29183694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile synthesis of (-)-vibo-quercitol from maltodextrin via an in vitro synthetic enzymatic biosystem.
    Bai X; Meng D; Wei X; Zhou X; Lu F; You C
    Biotechnol Bioeng; 2019 Oct; 116(10):2710-2719. PubMed ID: 31237686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolically engineered recombinant
    Al-Fahad AJ; Al-Fageeh MB; Kharbatia NM; Sioud S; Mahadevan R
    Metab Eng Commun; 2020 Dec; 11():e00134. PubMed ID: 32670790
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacillus subtilis iolU encodes an additional NADP
    Kang DM; Tanaka K; Takenaka S; Ishikawa S; Yoshida KI
    Biosci Biotechnol Biochem; 2017 May; 81(5):1026-1032. PubMed ID: 28043209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two scyllo-inositol dehydrogenases in Bacillus subtilis.
    Morinaga T; Ashida H; Yoshida KI
    Microbiology (Reading); 2010 May; 156(Pt 5):1538-1546. PubMed ID: 20133360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of glucocerebrosidase inhibitory activity of anhydro deoxyinositols from (+)-epi- and (-)-vibo-quercitols.
    Ogawa S; Uetsuki S; Tezuka Y; Morikawa T; Takahashi A; Sato K
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1493-8. PubMed ID: 10386923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease.
    Yamaoka M; Osawa S; Morinaga T; Takenaka S; Yoshida K
    Microb Cell Fact; 2011 Sep; 10():69. PubMed ID: 21896210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction to: Biosynthesis and production of quercitols and their application in the production of pharmaceuticals: current status and prospects.
    Itoh N
    Appl Microbiol Biotechnol; 2018 Nov; 102(21):9399-9401. PubMed ID: 30242434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus subtilis IolQ (DegA) is a transcriptional repressor of iolX encoding NAD
    Kang DM; Michon C; Morinaga T; Tanaka K; Takenaka S; Ishikawa S; Yoshida KI
    BMC Microbiol; 2017 Jul; 17(1):154. PubMed ID: 28693424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of valiolamine and some precursors for bioactive carbaglycosylamines from (-)-vibo-quercitol produced by biogenesis of myo-inositol.
    Ogawa S; Kanto M
    J Nat Prod; 2007 Mar; 70(3):493-7. PubMed ID: 17346079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production.
    Tanaka K; Natsume A; Ishikawa S; Takenaka S; Yoshida KI
    Microb Cell Fact; 2017 Apr; 16(1):67. PubMed ID: 28431560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of scyllo-Inositol: Conversion of Rice Bran into a Promising Disease-Modifying Therapeutic Agent for Alzheimer's Disease.
    Yoshida KI; Ishikawa S
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S139-S142. PubMed ID: 31619615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical studies on 2-deoxy-scyllo-inosose, an early intermediate in the biosynthesis of 2-deoxystreptamine. I. Chemical synthesis of 2-deoxy-scyllo-inosose and [2,2-2H2]-2-deoxy-scyllo-inosose.
    Yamauchi N; Kakinuma K
    J Antibiot (Tokyo); 1992 May; 45(5):756-66. PubMed ID: 1624377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convenient synthesis of 3- and 6-deoxy-D-myo-inositol phosphate analogues from (+)-epi- and (-)-vibo-quercitols.
    Ogawa S; Tezuka Y
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5238-43. PubMed ID: 16904317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A second-generation Bacillus cell factory for rare inositol production.
    Tanaka K; Takanaka S; Yoshida K
    Bioengineered; 2014; 5(5):331-4. PubMed ID: 25482235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic engineering of Corynebacterium glutamicum for production of scyllo-inositol, a drug candidate against Alzheimer's disease.
    Ramp P; Lehnert A; Matamouros S; Wirtz A; Baumgart M; Bott M
    Metab Eng; 2021 Sep; 67():173-185. PubMed ID: 34224896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convenient synthesis of (+)-valiolamine and (-)-1-epi-valiolamine from (-)-vibo-quercitol.
    Ogawa S; Ohishi Y; Asada M; Tomoda A; Takahashi A; Ooki Y; Mori M; Itoh M; Korenaga T
    Org Biomol Chem; 2004 Mar; 2(6):884-9. PubMed ID: 15007418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon-free production of 2-deoxy-scyllo-inosose (DOI) in cyanobacterium Synechococcus elongatus PCC 7942.
    Watanabe S; Ozawa H; Kato H; Nimura-Matsune K; Hirayama T; Kudo F; Eguchi T; Kakinuma K; Yoshikawa H
    Biosci Biotechnol Biochem; 2018 Jan; 82(1):161-165. PubMed ID: 29297252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.